Kaixin Medicine

Zhejiang Kaixin Pharmaceutical is a Chinese pharmaceutical company specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms, with a primary focus on central nervous system (CNS) therapeutics. Established in 1994 and headquartered in Xinchang, Zhejiang, the company has become a significant global supplier of anti-epileptic and neuropathic pain medications, most notably Gabapentin and Pregabalin. Their facilities are equipped with advanced synthesis and purification technologies, maintaining compliance with international regulatory standards including US FDA and EU GMP. In addition to its core CNS portfolio, the company produces cardiovascular and anti-infective agents. Kaixin Pharmaceutical's business model emphasizes high-volume production and international export, serving pharmaceutical markets across Asia, Europe, and North America.